Charles Weissmann

14 October 1931 – 12 December 2025

Written by Prof. Adriano Aguzzi to honor the memory of his friend and mentor.

A Scientific Giant

Charles Weissmann was a giant of 20th century science who created much of the bedrock of modern molecular biology. His discoveries have shaped entire disciplines—molecular biology, immunology, and neurodegeneration—yet he carried his brilliance with humility and good humor. His thinking was defined by precision, intellectual honesty, and a refusal to accept vague explanations. Those who collaborated with him quickly learned that his expectations were high, not out of severity, but out of respect for the scientific enterprise.

What made Charles exceptional was not only the originality of his discoveries but also the generosity with which he shared his insight, his time, and his wisdom. He cultivated talent, he challenged assumptions, and he inspired the people around him to think more clearly and to aspire higher. His laboratory was a place where rigor and enthusiasm coexisted, and where scientific ideas were treated with seriousness, curiosity, trepidation and joy.

Foundations of Molecular Precision

One of Charles Weissmann’s earliest and most enduring contributions was his role in the conceptual and experimental foundations of site-directed mutagenesis—the idea that one could introduce defined, intentional changes into a gene and thereby interrogate biological function with molecular precision. At a time when genetics was still largely descriptive and mutations were mostly accidents of nature or the result of relatively crude chemical or radiation treatments, Charles helped pioneer a radically different approach: rational genetic surgery. By deliberately altering specific nucleotides and observing the resulting phenotypic consequences, he enabled biology to move from correlation to causation. What distinguished Charles’s contribution was not only technical ingenuity but intellectual clarity. This way of thinking became a hallmark of his scientific style and influenced generations of molecular biologists.

Interferon and Biotechnology

The second chapter of Charles Weissmann’s scientific life unfolded at the interface of molecular biology, immunology, and medicine: the cloning of interferon. Before this work, interferon had been identified by Zurich virologist Jean Lindenmann in 1957 as an almost mythical substance—known primarily as a biological activity, detected indirectly through antiviral effects, present in vanishingly small quantities, and resistant to classical biochemical purification. Its therapeutic promise was enormous, but its molecular nature remained elusive.

Charles recognized that recombinant DNA technology offered a way forward. By cloning interferon genes, he transformed an abstract biological phenomenon into a defined molecular entity. This achievement required extraordinary technical courage at a time when cloning mammalian genes was still pioneering, difficult, and uncertain.

The consequences were immediate and far-reaching. Interferon could now be produced in sufficient quantities, characterized structurally, and studied mechanistically. What had once been a biological curiosity became one of the first true biopharmaceuticals, ushering in the era of recombinant protein therapeutics. This achievement led to the creation of Biogen in 1978, one of the world's foremost biotech companies co-founded by Charles.

Prion Biology and Intellectual Courage

The third chapter of Charles Weissmann’s career is arguably the most intellectually courageous: his decisive role in establishing the protein-only hypothesis of prions. When the idea emerged that infectious agents could exist without nucleic acids, it challenged one of biology’s most sacred principles. Charles approached the problem with disciplined skepticism and experimental rigor. Through genetic manipulation of the prion protein gene, transgenic models, and carefully controlled infectivity studies, Charles provided the clearest and most convincing evidence that prion propagation depends on host-encoded protein and not on hidden nucleic acids.

A Personal Encounter

I first met Charles Weissmann in 1988, when I was a young resident at the Institute of Neuropathology of the University of Zurich. His laboratory had just identified the gene encoding the prion protein, and I attended a research seminar in which he reviewed the state of prion biology at that time. While listening to Charles, it occurred to me that knocking out the prion protein gene might provide the ultimate proof of its necessity for prion replication. At the end of his seminar I asked him whether this experiment might be feasible. Charles immediately lit up, said that this was exactly what he was planning to do, and invited me to join his laboratory.

When I returned to Zurich in 1992, Charles welcomed me with extraordinary generosity. He became not only a scientific collaborator but a teacher of science and of life for the following two decades. During this period, I can truly say that I learned everything I know from Charles.

Mentorship and Laboratory Culture

The legendary Weissmann Laboratory Meetings were held every Saturday morning at 9AM, accompanied by breakfast and often extending until noon. Charles’s office bore the unforgettable sign: “WARNING: DO NOT ENTER THIS ROOM WITHOUT POSITIVE AND NEGATIVE CONTROLS”. Those meetings shaped not only my scientific thinking, but my approach to mentorship, leadership, and intellectual honesty.

A School of Thought

A defining measure of a scientist is not only the discoveries they make but the people they shape. Charles Weissmann created a school of thought—an intellectual lineage that continues to influence modern biology through the scientists he trained. Among them are leading figures in immunology, developmental biology, molecular genetics, and neuroscience whose work continues to shape science globally.

Legacy Beyond Papers

Charles reminded me many times that the important legacy of a scientist is not the number of papers they publish or the citations they accumulate, but rather how they are remembered by their trainees. He used to joke that the effective lifetime of a scientific paper is about three years, whereas the future lifetime of a trainee is 30–50 years. For that reason, the latter was infinitely more important.

In this sense, although Charles has left us physically, he lives on in the memory and gratitude of the entire school of scientists he created. His influence endures not only in those he trained directly, but also in future generations who continue his legacy of curiosity, scientific rigor, integrity, and clarity.